These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2959078)

  • 1. Gastric and systemic effects of carbenoxolone and its derivative ISF 2715 in humans.
    Velo GP; Minuz P; Riela A; Brocco G; Degan M; Franco L; Cavallini G
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():361-5. PubMed ID: 2959078
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of carbenoxolone on gastric prostaglandin E release and cytoprotection in the rat.
    Martin A; Gurrieri G; Sturniolo GC; Naccarato R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():409-10. PubMed ID: 6221623
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of carbenoxolone on gastric release of prostaglandin (PG)E2 in patients with peptic ulcer disease.
    Rask-Madsen J; Bukhave K; Madsen PE; Bekker C
    Acta Gastroenterol Belg; 1983; 46(9-10):419-28. PubMed ID: 6585111
    [No Abstract]   [Full Text] [Related]  

  • 4. [Behavior of gastrin, renin, aldosterone and electrolytes after administration of deglycyrrhizinized liquorice and carbenoxolone in healthy subjects].
    Baas EU; Holtermüller KH; Sinterhauf K; Walter U
    Z Gastroenterol; 1976 Apr; 14(2):273-6. PubMed ID: 802922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-ulcer activity of carbenoxolone and ISF 3401 on PGE2 release in rat gastric mucosa.
    Franco L; Manara P; Erbetti I; Velo GP
    Pharmacol Res; 1993; 27(2):141-50. PubMed ID: 8474959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric antiulcer and antisecretory effects of carbenoxolone, aldosterone and desoxycorticosterone in rats.
    Dajani EZ; Bianchi RG; Casler JJ; Weet JF
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):128-38. PubMed ID: 543742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular action of a new carbenoxolone derivative.
    Filczewski M; Kosmala M; Oledzka K
    Pol J Pharmacol Pharm; 1988; 40(3):233-9. PubMed ID: 3241764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbenoxolone and prostaglandin E2 and F2 alpha gastric juice levels in man.
    Minuz P; Cavallini G; Angelini GP; Lechi A; Brocco G; Riela A; Scuro LA; Velo GP
    Pharmacol Res Commun; 1984 Sep; 16(9):875-84. PubMed ID: 6594711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of somatostatin on prostaglandin E2 gastric intraluminal release in humans.
    Materia A; Jaffe BM; Mariani P; Silecchia G; Genco A; Bagarani M; Basso N
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():318-21. PubMed ID: 2889332
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of carbenoxolone on prostaglandin synthesizing and metabolizing enzymes and correlation with gastric mucosal carbenoxolone concentrations.
    Peskar BM
    Scand J Gastroenterol Suppl; 1980; 65():109-14. PubMed ID: 6259713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal cell turnover in the upper gut of the mouse and its modification by carbenoxolone [proceedings].
    Henman FD; Adams SS
    Br J Pharmacol; 1978 Nov; 64(3):426P-427P. PubMed ID: 719277
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastric gel mucus thickness: effect of distention, 16,16-dimethyl prostaglandin e2, and carbenoxolone.
    Bickel M; Kauffman GL
    Gastroenterology; 1981 Apr; 80(4):770-5. PubMed ID: 6162705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of leukotriene formation as a mode of action of gastroprotective drugs.
    Lange K; Peskar BA; Peskar BM
    Prog Clin Biol Res; 1987; 242():283-8. PubMed ID: 3671388
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of carbenoxolone on the gastric mucosal prostaglandin and thromboxane system.
    Peskar BM
    Acta Gastroenterol Belg; 1983; 46(9-10):429-36. PubMed ID: 6324520
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer.
    Parodi MC; Molinari F; Barocci S
    Scand J Gastroenterol Suppl; 1984; 92():163-6. PubMed ID: 6234649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of carbenoxolone and prostaglandin E2 on transmucosal potential difference in the rat stomach.
    Watanabe K; Yano S; Yamaguchi T
    Scand J Gastroenterol Suppl; 1989; 162():87-90. PubMed ID: 2595316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of carbenoxolone on gastric prostaglandin E2 levels in patients with peptic ulcer disease following vagal and pentagastrin stimulation.
    Rask-Madsen J; Bukhave K; Madsen PE; Bekker C
    Eur J Clin Invest; 1983 Aug; 13(4):351-6. PubMed ID: 6413222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbenoxolone and deglycyrrhized liquorice have little or no effect on prostanoid synthesis by rat gastric mucosa ex vivo.
    Bennett A; Melhuish PB; Stamford IF
    Br J Pharmacol; 1985 Nov; 86(3):693-5. PubMed ID: 3840708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cimetidine, carbenoxolone and gastric mucus.
    Guslandi M
    Gut; 1988 Sep; 29(9):1293-4. PubMed ID: 3198010
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of antisecretory drugs on mucosal erosions induced by intragastric distension in rats: a comparative study.
    Martí-Cabrera M; Esplugues JV; Martí-Bonmati L; Sarria B; Vento A; Martí-Bonmati E; Gil L; Esplugues J
    Methods Find Exp Clin Pharmacol; 1988 Jan; 10(1):13-6. PubMed ID: 3162756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.